Tuning Fork Bio will launch its business in collaboration with the Translational Research Center at Fukushima Medical University. The Translational Research Center has developed protein microarrays utilizing technology that transfers proteins onto glass slides at high densities (more than 10,000 types). By measuring the binding state of proteins (antigens) on the microarray with the antibodies in the blood, it is possible to comprehensively search for the antibodies an individual has in their body. Exceeding 20,000 types in total, the number of protein samples the Translational Research Center has prepared is among the highest in the world and includes not only human proteins but also proteins from viruses and bacteria.
Tuning Fork Bio analyzes protein microarray data using proprietary bioinformatics technology to select antibodies suitable for use as biomarkers for assessing health conditions, diagnoses, etc., and constructs systems applicable for performing diagnoses.
By comparing an individual’s antibodies with data when sick and data when healthy, health risks can be easier to perceive. Tuning Fork Bio aims to offer diagnostic services aiding more positive life planning for people by helping prevent the onset of sickness and facilitating the selection of medications that best fit each individual’s conditions.